← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 1, 2019Last known activity
Mar 31, 2025
Timeline
2010s
- Jun 1, 2011
ONL Therapeutics— Founded
Drugs by trial phase (2 distinct, 5 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06659445Lead sponsorPhase 2Mar 31, 2025
- NCT05730218Lead sponsorPhase 2Apr 4, 2023
- NCT05160805Lead sponsorPhase 1Feb 28, 2022
- NCT04744662Lead sponsorPhase 1Jul 8, 2021
- NCT03780972Lead sponsorPhase 1Feb 1, 2019
Details
- Founded
- Ann Arbor, MI, US Jun 1, 2011
- Last known activity
- Mar 31, 2025